The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

S. Kusamura; Pilar Adriana Torres Mesa; A. Cabras; Dario Baratti; M. Deraco

doi:10.1245/s10434-015-4962-9

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

S. Kusamura, Pilar Adriana Torres Mesa, A. Cabras, Dario Baratti, M. Deraco

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1468-1473
Number of pages	6
Journal	Annals of Surgical Oncology
Volume	23
Issue number	5
DOIs	https://doi.org/10.1245/s10434-015-4962-9
Publication status	Published - 2016

Access to Document

10.1245/s10434-015-4962-9

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947080371&doi=10.1245%2fs10434-015-4962-9&partnerID=40&md5=0017a4071769f5c76df67b23483b684d

Cite this

Kusamura, S., Torres Mesa, P. A., Cabras, A., Baratti, D., & Deraco, M. (2016). The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Annals of Surgical Oncology, 23(5), 1468-1473. https://doi.org/10.1245/s10434-015-4962-9

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). / Kusamura, S.; Torres Mesa, Pilar Adriana; Cabras, A.; Baratti, Dario ; Deraco, M.

In: Annals of Surgical Oncology, Vol. 23, No. 5, 2016, p. 1468-1473.

Research output: Contribution to journal › Article › peer-review

Kusamura, S, Torres Mesa, PA, Cabras, A , Baratti, D & Deraco, M 2016, 'The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)', Annals of Surgical Oncology, vol. 23, no. 5, pp. 1468-1473. https://doi.org/10.1245/s10434-015-4962-9

@article{e4b0564b08d2448490be16cdc7795ba4,

title = "The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)",

author = "S. Kusamura and {Torres Mesa}, {Pilar Adriana} and A. Cabras and Dario Baratti and M. Deraco",

note = "Cited By :1 Export Date: 8 March 2017",

year = "2016",

doi = "10.1245/s10434-015-4962-9",

language = "English",

volume = "23",

pages = "1468--1473",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York LLC",

number = "5",

}

TY - JOUR

T1 - The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

AU - Kusamura, S.

AU - Torres Mesa, Pilar Adriana

AU - Cabras, A.

AU - Baratti, Dario

AU - Deraco, M.

N1 - Cited By :1 Export Date: 8 March 2017

PY - 2016

Y1 - 2016

U2 - 10.1245/s10434-015-4962-9

DO - 10.1245/s10434-015-4962-9

M3 - Article

VL - 23

SP - 1468

EP - 1473

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 5

ER -